hematologic and lymphocytic disorder
Showing 1 - 9 of 9
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,
Active, not recruiting
- Acute Leukemia
- +4 more
- Fludarabine
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in United States (drug, other, biological)
Recruiting
- Hematologic and Lymphocytic Disorder
- Hematopoietic and Lymphoid Cell Neoplasm
- Placebo Administration
- +3 more
-
Duarte, California
- +3 more
Dec 14, 2022
Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,
Recruiting
- Acute Myeloid Leukemia in Remission
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 1, 2022
Hematologic and Lymphocytic Disorder Trial in Houston (Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan,
Recruiting
- Hematologic and Lymphocytic Disorder
- Allogeneic Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Guardian, Hematologic and Lymphocytic Disorder, Malignant Tumor Trial in Buffalo (Educational Activity, Patient Monitoring,
Completed
- Guardian
- +3 more
- Educational Activity
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 13, 2021
Allogeneic Stem Cell Transplant Recipient, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in
Withdrawn
- Allogeneic Stem Cell Transplant Recipient
- +2 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2020
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (Platelet Transfusion)
Terminated
- Acute Biphenotypic Leukemia
- +13 more
- Platelet Transfusion
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2019